Clinical Endocrinology

Journal

Publication Venue For

  • TSH receptor specific monoclonal autoantibody K1-70TM targeting of the TSH receptor in subjects with Graves' disease and Graves' orbitopathy—Results from a phase I clinical trial.  96:878-887. 2022
  • Natural history of polycystic ovary syndrome: A systematic review of cardiometabolic outcomes from longitudinal cohort studies.  96:475-498. 2022
  • Racial and ethnic differences in the metabolic response of polycystic ovary syndrome.  93:163-172. 2020
  • Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin-mediated and non–insulin-mediated whole-body glucose uptake.  90:542-552. 2019
  • Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.  89:251-268. 2018
  • Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.  85:400-407. 2016
  • Basal metabolic rate in women with PCOS compared to eumenorrheic controls.  83:384-388. 2015
  • Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females.  82:550-556. 2015
  • Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS.  79:550-557. 2013
  • Haplotype effect in the IGF1 promoter accounts for the association between microsatellite and serum IGF1 concentration..  74:520-527. 2011
  • Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample.  73:404-412. 2010
  • Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension.  71:434-439. 2009
  • Vitamin D and bone health in adults with cystic fibrosis.  69:374-381. 2008
  • Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).  62:644-649. 2005
  • EFFECTS OF LOW DOSE ORAL IODIDE SUPPLEMENTATION ON THYROID FUNCTION IN NORMAL MEN.  28:283-288. 1988
  • HYPERPROLACTINAEMIA IN CONGENITAL HYPOTHYROIDISM.  24:285-290. 1986
  • Proopiomelanocortin-derived peptides in the immune system..  22:823-827. 1985
  • PROOPIOMELANOCORTIN‐DERIVED PEPTIDES IN THE IMMUNE SYSTEM.  22:823-827. 1985

    • International Standard Serial Number (issn)

  • 0300-0664

    • Electronic International Standard Serial Number (eissn)

  • 1365-2265